CSL - Beneficio Operativo

Precio De Mercado
139.19
Cambio Diario
-1.04 -0.74%
Mensual
-2.38%
Anual
-40.28%
Q2 Expectativa
136.36




Beneficio Operativo Cambio Fecha
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Arca Biopharma USD -34.43M 326K 2025-12
aTyr Pharma USD 24.47M 51.21M 2025-12
Bio Path USD -488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD -2.24M 197K 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
CSL USD 2.64B 1.97B 2025-12
Curis USD -7.88M 4.63M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Immunic USD -25.73M 2.91M 2024-09
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
TherapeuticsMD USD -1.18M 40K 2024-06